Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The history now includes a new revision entry v3.5.4; the previous entry v3.5.3 was removed.
    Difference
    0.0%
    Check dated 2026-05-15T06:23:05.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer has been updated to reflect a newer ClinicalTrials.gov interface/release revision (v3.5.3 instead of v3.5.2).
    Difference
    0.0%
    Check dated 2026-04-24T06:41:33.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now listed as the latest entry, and Revision: v3.5.0 has been removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:55:59.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision history updated: added version v3.5.0 and removed version v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T08:41:19.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry v3.4.3 and removes v3.4.2 from the history.
    Difference
    0.0%
    Check dated 2026-03-12T04:57:46.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history and removed the government-funding notices along with the older Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-11T16:32:24.000Z thumbnail image

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.